1. Аverina I.А., Sergienko D.F., Dugugieva O.S., Gadzhiev R.M. Chronic pulmonary diseases in the context of immunogenetic impact of vitamin D. Uspekhi Sovremennoy Nauki, 2017, vol. 24, no. 4, pp. 209-218. (In Russ.)
2. Аllakhverdieva L.I.G., Sultanova N.G.G., Dzhafarova А.O.G. The effect of pharmacological therapy with vitamin D on the cytokine response in children with atopic bronchial asthma. Kazanskiy Meditsinskiy Journal, 2019, vol. 100, no. 1, pp. 135-139. (In Russ.)
3. Аkhmetova А.А. FOKI, TAGI, BSMI, APAI, and CDX2 vitamin D receptor (VDR) polymorphism with susceptibility to pulmonary tuberculosis: a comparative analysis. Vestnik KGMА Im. I.K. Аkhunbaeva, 2018, no. 4, pp. 17-23. (In Russ.)
4. Belyaeva I.V., Nikolaev А.V., Churilov L.P., Yablonskiy P.K. Cathelicidins, vitamin D and tuberculosis. Vestnik Sankt-Peterburgskogo Universiteta, Meditsina, 2013, no. 3, pp. 3-18. (In Russ.)
5. Bolotova E.V., Yavlyanskaya V.V., Dudnikova А.V. Cardiorenal relationships and a role of vitamin D in patients with chronic obstructive pulmonary disease. Pulmonoloiya, 2018, vol. 28, no. 5, pp. 613-621. (In Russ.)